Search research articles
Contact Us
Filters
Showing results (71-80 of 106) with videos related to
Page
of 11
Sort By:
The Oncologist
|
November 17, 2025
Best therapeutic approach in metastatic hormone-sensitive prostate cancer based on disease volume: a systematic review and network meta-analysis
Fabrizio Di Costanzo, Chiara Mercinelli, Alessio Signori, et al.
Bone Marrow Transplantation
|
January 14, 2018
Adjuvant role of SeptiFast to improve the diagnosis of sepsis in a large cohort of hematological patients
Raffaella Greco, Maria Chiara Barbanti, Nicasio Mancini, et al.
Expert Review of Anticancer Therapy
|
November 5, 2021
Cabozantinib beyond progression improves survival in advanced renal cell carcinoma patients: the CABEYOND study (Meet-URO 21)
Alessia Mennitto, Emma Zattarin, Massimo Di Maio, et al.
European Journal of Cancer (Oxford, England : 1990)
|
October 22, 2020
Incidence and outcomes of severe acute respiratory syndrome coronavirus 2 infection in patients with metastatic castration-resistant prostate cancer
Orazio Caffo, Donatello Gasparro, Giuseppe Di Lorenzo, et al.
Liver Cancer
|
August 20, 2021
Real-Life Clinical Data of Cabozantinib for Unresectable Hepatocellular Carcinoma
Francesco Tovoli, Vincenzo Dadduzio, Stefania De Lorenzo, et al.
Cancer Immunology, Immunotherapy : CII
|
January 3, 2025
First-line immune-based combinations or sunitinib in favorable-risk metastatic renal cell carcinoma: a real-world retrospective comparison from the ARON-1 study
Giandomenico Roviello, Javier Molina-Cerrillo, Francesco Massari, et al.
Clinical Hematology International
|
October 1, 2021
Nanosphere's Verigene<sup>®</sup> Blood Culture Assay to Detect Multidrug-Resistant Gram-Negative Bacterial Outbreak: A Prospective Study on 79 Hematological Patients in a Country with High Prevalence of Antimicrobial Resistance
Raffaella Greco, Maria Chiara Barbanti, Nicasio Mancini, et al.
Targeted Oncology
|
August 6, 2024
Pembrolizumab in Patients with Advanced Urothelial Carcinoma with ECOG Performance Status 2: A Real-World Study from the ARON-2 Project
Alessandro Rizzo, Fernando Sabino Marques Monteiro, Yüksel Ürün, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 29, 2020
Characterizing CDK12-Mutated Prostate Cancers
Pasquale Rescigno, Bora Gurel, Rita Pereira, et al.
The Oncologist
|
December 2, 2025
Homologous recombination repair genetic testing variables and diagnostic paths for prostate cancer patients: a multicenter cohort study
Lorena Incorvaia, Mattia Puglisi, Marco Maruzzo, et al.
Page
of 11
Search research articles
Search
Showing results (71-80 of 106) with videos related to
Sort By:
Page
of 11
The Oncologist
|
November 17, 2025
Best therapeutic approach in metastatic hormone-sensitive prostate cancer based on disease volume: a systematic review and network meta-analysis
Fabrizio Di Costanzo, Chiara Mercinelli, Alessio Signori, et al.
Bone Marrow Transplantation
|
January 14, 2018
Adjuvant role of SeptiFast to improve the diagnosis of sepsis in a large cohort of hematological patients
Raffaella Greco, Maria Chiara Barbanti, Nicasio Mancini, et al.
Expert Review of Anticancer Therapy
|
November 5, 2021
Cabozantinib beyond progression improves survival in advanced renal cell carcinoma patients: the CABEYOND study (Meet-URO 21)
Alessia Mennitto, Emma Zattarin, Massimo Di Maio, et al.
European Journal of Cancer (Oxford, England : 1990)
|
October 22, 2020
Incidence and outcomes of severe acute respiratory syndrome coronavirus 2 infection in patients with metastatic castration-resistant prostate cancer
Orazio Caffo, Donatello Gasparro, Giuseppe Di Lorenzo, et al.
Liver Cancer
|
August 20, 2021
Real-Life Clinical Data of Cabozantinib for Unresectable Hepatocellular Carcinoma
Francesco Tovoli, Vincenzo Dadduzio, Stefania De Lorenzo, et al.
Cancer Immunology, Immunotherapy : CII
|
January 3, 2025
First-line immune-based combinations or sunitinib in favorable-risk metastatic renal cell carcinoma: a real-world retrospective comparison from the ARON-1 study
Giandomenico Roviello, Javier Molina-Cerrillo, Francesco Massari, et al.
Clinical Hematology International
|
October 1, 2021
Nanosphere's Verigene<sup>®</sup> Blood Culture Assay to Detect Multidrug-Resistant Gram-Negative Bacterial Outbreak: A Prospective Study on 79 Hematological Patients in a Country with High Prevalence of Antimicrobial Resistance
Raffaella Greco, Maria Chiara Barbanti, Nicasio Mancini, et al.
Targeted Oncology
|
August 6, 2024
Pembrolizumab in Patients with Advanced Urothelial Carcinoma with ECOG Performance Status 2: A Real-World Study from the ARON-2 Project
Alessandro Rizzo, Fernando Sabino Marques Monteiro, Yüksel Ürün, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 29, 2020
Characterizing CDK12-Mutated Prostate Cancers
Pasquale Rescigno, Bora Gurel, Rita Pereira, et al.
The Oncologist
|
December 2, 2025
Homologous recombination repair genetic testing variables and diagnostic paths for prostate cancer patients: a multicenter cohort study
Lorena Incorvaia, Mattia Puglisi, Marco Maruzzo, et al.
Page
of 11